In November 2020, Precision Medicine Group secured a major investment commitment from Blackstone, one of the world’s leading investment firms with a significant focus on healthcare and technology. Blackstone joined the existing group of notable Precision investors such as Berkshire Partners, TPG Growth, Oak HC/FT, and Vida Ventures.

In this interview, Blackstone’s senior leadership, Julia Kahr, Anushka Sunder and Natasha Gopaul discuss the firm’s investment with PMG, how the deal came together, as well as their experiences as senior women in the private equity industry.

Read more here!